[
    {
        "pk": 18, 
        "model": "Interaction.article", 
        "fields": {
            "Title": null, 
            "PMCXML": "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\">\n<pmc-articleset>\n <article article-type=\"research-article\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">\n  <!--The publisher of this article does not allow downloading of the full text in XML form.-->\n  <front>\n   <journal-meta>\n    <journal-id journal-id-type=\"nlm-ta\">\n     J Virol\n    </journal-id>\n    <journal-id journal-id-type=\"publisher-id\">\n     J VIROL\n    </journal-id>\n    <journal-title>\n     Journal of Virology\n    </journal-title>\n    <issn pub-type=\"ppub\">\n     0022-538X\n    </issn>\n    <issn pub-type=\"epub\">\n     1098-5514\n    </issn>\n    <publisher>\n     <publisher-name>\n      American Society for Microbiology\n     </publisher-name>\n    </publisher>\n   </journal-meta>\n   <article-meta>\n    <article-id pub-id-type=\"pmc\">\n     104048\n    </article-id>\n    <article-id pub-id-type=\"pmid\">\n     10074138\n    </article-id>\n    <article-id pub-id-type=\"publisher-id\">\n     1229\n    </article-id>\n    <article-categories>\n     <subj-group subj-group-type=\"heading\">\n      <subject>\n       Structure and Assembly\n      </subject>\n     </subj-group>\n    </article-categories>\n    <title-group>\n     <article-title>\n      Interaction of the Human Immunodeficiency Virus  Type 1 Nucleocapsid with Actin\n     </article-title>\n    </title-group>\n    <contrib-group>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Liu\n       </surname>\n       <given-names>\n        Bindong\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x9d41240.0x9913a30\">\n       1\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Dai\n       </surname>\n       <given-names>\n        Renke\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x9d41240.0x9913a30\">\n       2\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Tian\n       </surname>\n       <given-names>\n        Chun-Juan\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x9d41240.0x9913a30\">\n       1\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Dawson\n       </surname>\n       <given-names>\n        Liza\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x9d41240.0x9913a30\">\n       1\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Gorelick\n       </surname>\n       <given-names>\n        Robert\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x9d41240.0x9913a30\">\n       3\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Yu\n       </surname>\n       <given-names>\n        Xiao-Fang\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"N0x9d41240.0x9913a30\">\n       1\n      </xref>\n      <xref ref-type=\"author-notes\" rid=\"FN150\">\n       &#x0002a;\n      </xref>\n     </contrib>\n    </contrib-group>\n    <aff id=\"N0x9d41240.0x9913a30\">\n     Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205\n     <sup>\n      1\n     </sup>\n     ;  Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892\n     <sup>\n      2\n     </sup>\n     ; and  AIDS Vaccine Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702\n     <sup>\n      3\n     </sup>\n    </aff>\n    <author-notes>\n     <fn id=\"FN150\">\n      <label>\n       &#x0002a;\n      </label>\n      <p>\n       Corresponding author. Mailing address: Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Hygiene and Public Health, Room E4012, 615 N. Wolfe St., Baltimore, MD 21205. Phone: (410) 955-3768. Fax: (410) 614-8263. E-mail:\n       <email>\n        xfyu@jhsph.edu\n       </email>\n       .\n      </p>\n     </fn>\n    </author-notes>\n    <pub-date pub-type=\"ppub\">\n     <month>\n      4\n     </month>\n     <year>\n      1999\n     </year>\n    </pub-date>\n    <volume>\n     73\n    </volume>\n    <issue>\n     4\n    </issue>\n    <fpage>\n     2901\n    </fpage>\n    <lpage>\n     2908\n    </lpage>\n    <history>\n     <date date-type=\"received\">\n      <day>\n       28\n      </day>\n      <month>\n       7\n      </month>\n      <year>\n       1998\n      </year>\n     </date>\n     <date date-type=\"accepted\">\n      <day>\n       14\n      </day>\n      <month>\n       12\n      </month>\n      <year>\n       1998\n      </year>\n     </date>\n    </history>\n    <copyright-statement>\n     Copyright &#x000a9; 1999, American Society for Microbiology\n    </copyright-statement>\n    <copyright-year>\n     1999\n    </copyright-year>\n    <abstract>\n     <p>\n      The nucleocapsid (NC) domain of the retrovirus Gag protein plays several important roles in the viral life cycle, including virus assembly, viral genomic RNA encapsidation, primer tRNA placement, and enhancement of viral reverse transcription. In this study, deletion of NC domain of human immunodeficiency virus type 1 (HIV-1) Gag was found to drastically reduce virus particle production in CD4\n      <sup>\n       &#x0002b;\n      </sup>\n      T cells. Cellular fractionation experiments showed that although most of the uncleaved wild-type HIV-1 Gag, unmyristylated Gag, and  p6\n      <sup>\n       Gag\n      </sup>\n      domain-truncated Gag molecules copurified with the host cell cytoskeleton, most of the mutant Gag molecules lacking both the NC and p6\n      <sup>\n       Gag\n      </sup>\n      domains failed to cofractionate with cytoskeleton. In wild-type virus-infected cells, in which the viral protease was active, the cleaved NCp7 copurified with the cytoskeleton, whereas most of the MAp17 and CAp24 did not. Monoclonal antibody against actin coimmunoprecipitated full-length Gag and p6\n      <sup>\n       Gag\n      </sup>\n      domain-truncated Gag molecules from cell lysates but failed to precipitate the truncated mutant Gag molecules lacking NC plus p6\n      <sup>\n       Gag\n      </sup>\n      . Purified recombinant NCp7, but not CAp24, was able to bind F-actin in cosedimentation experiments. Furthermore, wild-type NCp7 and a zinc finger mutant NCp7(F16A), like a cellular actin-binding protein (the villin headpiece), bound F-actin in a dose-dependent fashion in vitro. Taken together, these results suggest that HIV-1 NCp7 can bind F-actin directly and that interaction between HIV-1 Gag and the actin cytoskeleton through the NC domain may play an important role in HIV-1 assembly and/or other steps of the viral life cycle.\n     </p>\n    </abstract>\n   </article-meta>\n  </front>\n </article>\n</pmc-articleset>\n", 
            "Interactions": [
                675, 
                694
            ], 
            "PubMedXML": "<pubmedarticle>\n<medlinecitation owner=\"NLM\" status=\"MEDLINE\">\n <pmid>\n  10074138\n </pmid>\n <datecreated>\n  <year>\n   1999\n  </year>\n  <month>\n   05\n  </month>\n  <day>\n   06\n  </day>\n </datecreated>\n <datecompleted>\n  <year>\n   1999\n  </year>\n  <month>\n   05\n  </month>\n  <day>\n   06\n  </day>\n </datecompleted>\n <daterevised>\n  <year>\n   2009\n  </year>\n  <month>\n   11\n  </month>\n  <day>\n   18\n  </day>\n </daterevised>\n <article pubmodel=\"Print\">\n  <journal>\n   <issn issntype=\"Print\">\n    0022-538X\n   </issn>\n   <journalissue citedmedium=\"Print\">\n    <volume>\n     73\n    </volume>\n    <issue>\n     4\n    </issue>\n    <pubdate>\n     <year>\n      1999\n     </year>\n     <month>\n      Apr\n     </month>\n    </pubdate>\n   </journalissue>\n   <title>\n    Journal of virology\n   </title>\n   <isoabbreviation>\n    J. Virol.\n   </isoabbreviation>\n  </journal>\n  <articletitle>\n   Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.\n  </articletitle>\n  <pagination>\n   <medlinepgn>\n    2901-8\n   </medlinepgn>\n  </pagination>\n  <abstract>\n   <abstracttext>\n    The nucleocapsid (NC) domain of the retrovirus Gag protein plays several important roles in the viral life cycle, including virus assembly, viral genomic RNA encapsidation, primer tRNA placement, and enhancement of viral reverse transcription. In this study, deletion of NC domain of human immunodeficiency virus type 1 (HIV-1) Gag was found to drastically reduce virus particle production in CD4(+) T cells. Cellular fractionation experiments showed that although most of the uncleaved wild-type HIV-1 Gag, unmyristylated Gag, and p6(Gag) domain-truncated Gag molecules copurified with the host cell cytoskeleton, most of the mutant Gag molecules lacking both the NC and p6(Gag) domains failed to cofractionate with cytoskeleton. In wild-type virus-infected cells, in which the viral protease was active, the cleaved NCp7 copurified with the cytoskeleton, whereas most of the MAp17 and CAp24 did not. Monoclonal antibody against actin coimmunoprecipitated full-length Gag and p6(Gag) domain-truncated Gag molecules from cell lysates but failed to precipitate the truncated mutant Gag molecules lacking NC plus p6(Gag). Purified recombinant NCp7, but not CAp24, was able to bind F-actin in cosedimentation experiments. Furthermore, wild-type NCp7 and a zinc finger mutant NCp7(F16A), like a cellular actin-binding protein (the villin headpiece), bound F-actin in a dose-dependent fashion in vitro. Taken together, these results suggest that HIV-1 NCp7 can bind F-actin directly and that interaction between HIV-1 Gag and the actin cytoskeleton through the NC domain may play an important role in HIV-1 assembly and/or other steps of the viral life cycle.\n   </abstracttext>\n  </abstract>\n  <affiliation>\n   Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205, USA.\n  </affiliation>\n  <authorlist completeyn=\"Y\">\n   <author validyn=\"Y\">\n    <lastname>\n     Liu\n    </lastname>\n    <forename>\n     B\n    </forename>\n    <initials>\n     B\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Dai\n    </lastname>\n    <forename>\n     R\n    </forename>\n    <initials>\n     R\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Tian\n    </lastname>\n    <forename>\n     C J\n    </forename>\n    <initials>\n     CJ\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Dawson\n    </lastname>\n    <forename>\n     L\n    </forename>\n    <initials>\n     L\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Gorelick\n    </lastname>\n    <forename>\n     R\n    </forename>\n    <initials>\n     R\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Yu\n    </lastname>\n    <forename>\n     X F\n    </forename>\n    <initials>\n     XF\n    </initials>\n   </author>\n  </authorlist>\n  <language>\n   eng\n  </language>\n  <grantlist completeyn=\"Y\">\n   <grant>\n    <grantid>\n     AI-35525\n    </grantid>\n    <acronym>\n     AI\n    </acronym>\n    <agency>\n     NIAID NIH HHS\n    </agency>\n    <country>\n     United States\n    </country>\n   </grant>\n   <grant>\n    <grantid>\n     N01-CO-56000\n    </grantid>\n    <acronym>\n     CO\n    </acronym>\n    <agency>\n     NCI NIH HHS\n    </agency>\n    <country>\n     United States\n    </country>\n   </grant>\n  </grantlist>\n  <publicationtypelist>\n   <publicationtype>\n    Journal Article\n   </publicationtype>\n   <publicationtype>\n    Research Support, U.S. Gov't, P.H.S.\n   </publicationtype>\n  </publicationtypelist>\n </article>\n <medlinejournalinfo>\n  <country>\n   UNITED STATES\n  </country>\n  <medlineta>\n   J Virol\n  </medlineta>\n  <nlmuniqueid>\n   0113724\n  </nlmuniqueid>\n  <issnlinking>\n   0022-538X\n  </issnlinking>\n </medlinejournalinfo>\n <chemicallist>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Actins\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Gene Products, gag\n   </nameofsubstance>\n  </chemical>\n </chemicallist>\n <citationsubset>\n  IM\n </citationsubset>\n <citationsubset>\n  X\n </citationsubset>\n <commentscorrectionslist>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Mar;72(3):1782-9\n   </refsource>\n   <pmid>\n    9499028\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Apr;72(4):2723-32\n   </refsource>\n   <pmid>\n    9525590\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Apr;72(4):3412-7\n   </refsource>\n   <pmid>\n    9525672\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Nov;72(11):9034-44\n   </refsource>\n   <pmid>\n    9765448\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Nov;72(11):9061-8\n   </refsource>\n   <pmid>\n    9765451\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1998 Nov 10;251(1):141-57\n   </refsource>\n   <pmid>\n    9813210\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Curr Top Microbiol Immunol. 1996;214:25-63\n   </refsource>\n   <pmid>\n    8791724\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1996 Oct;70(10):7132-42\n   </refsource>\n   <pmid>\n    8794360\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Biochemistry. 1996 Oct 1;35(39):12677-85\n   </refsource>\n   <pmid>\n    8841111\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Gen Virol. 1995 Dec;76 ( Pt 12):3171-9\n   </refsource>\n   <pmid>\n    8847526\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1996 Oct 1;224(1):302-9\n   </refsource>\n   <pmid>\n    8862425\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1996 Nov;70(11):7734-43\n   </refsource>\n   <pmid>\n    8892894\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1997 Feb;71(2):1443-52\n   </refsource>\n   <pmid>\n    8995670\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Nat Struct Biol. 1997 May;4(5):366-9\n   </refsource>\n   <pmid>\n    9145106\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1997 May 27;94(11):5679-84\n   </refsource>\n   <pmid>\n    9159132\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Mol Biol. 1997 May 2;268(2):250-60\n   </refsource>\n   <pmid>\n    9159468\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Nat Struct Biol. 1997 Mar;4(3):180-4\n   </refsource>\n   <pmid>\n    9164455\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1997 Jul;71(7):5178-88\n   </refsource>\n   <pmid>\n    9188585\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1997 Sep;71(9):6765-76\n   </refsource>\n   <pmid>\n    9261401\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1997 Sep;71(9):6973-81\n   </refsource>\n   <pmid>\n    9261426\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1998 Mar 30;243(1):78-93\n   </refsource>\n   <pmid>\n    9527917\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1998 Mar 30;243(1):167-77\n   </refsource>\n   <pmid>\n    9527926\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 May;72(5):3658-65\n   </refsource>\n   <pmid>\n    9557646\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Gen Virol. 1992 Dec;73 ( Pt 12):3079-86\n   </refsource>\n   <pmid>\n    1469349\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Trends Cell Biol. 1996 Jan;6(1):9-15\n   </refsource>\n   <pmid>\n    15157526\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1992 Apr;66(4):1856-65\n   </refsource>\n   <pmid>\n    1548743\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Cell. 1992 Jul 10;70(1):81-92\n   </refsource>\n   <pmid>\n    1623524\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6472-6\n   </refsource>\n   <pmid>\n    1631144\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    AIDS. 1991 Jun;5(6):639-54\n   </refsource>\n   <pmid>\n    1883539\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9\n   </refsource>\n   <pmid>\n    2014240\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1990 May;64(5):1920-6\n   </refsource>\n   <pmid>\n    2109098\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Mol Biol. 1990 Dec 5;216(3):689-99\n   </refsource>\n   <pmid>\n    2124274\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1990 Oct;64(10):5230-4\n   </refsource>\n   <pmid>\n    2204725\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7\n   </refsource>\n   <pmid>\n    2405382\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5\n   </refsource>\n   <pmid>\n    2788277\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Cell Biol. 1987 Oct;105(4):1473-8\n   </refsource>\n   <pmid>\n    3312229\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1984 Nov;52(2):492-500\n   </refsource>\n   <pmid>\n    6333515\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1995 Nov;69(11):6810-8\n   </refsource>\n   <pmid>\n    7474093\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    EMBO J. 1994 Feb 15;13(4):973-81\n   </refsource>\n   <pmid>\n    7509280\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Biochemistry. 1994 Nov 22;33(46):13817-23\n   </refsource>\n   <pmid>\n    7524664\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 1995 Jun 23;270(25):15005-11\n   </refsource>\n   <pmid>\n    7541033\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Mol Biol. 1995 Oct 6;252(5):563-71\n   </refsource>\n   <pmid>\n    7563074\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1995 Sep;69(9):5455-60\n   </refsource>\n   <pmid>\n    7636991\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1995 Oct;69(10):6487-97\n   </refsource>\n   <pmid>\n    7666550\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Mol Biol. 1993 May 20;231(2):185-90\n   </refsource>\n   <pmid>\n    7685391\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2026-30\n   </refsource>\n   <pmid>\n    7892219\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1994 Aug;68(8):5311-20\n   </refsource>\n   <pmid>\n    8035531\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1994 Apr;68(4):2556-69\n   </refsource>\n   <pmid>\n    8139035\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1994 May;68(5):2898-905\n   </refsource>\n   <pmid>\n    8151760\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1994 May;68(5):3232-42\n   </refsource>\n   <pmid>\n    8151785\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1993 Nov;197(1):245-54\n   </refsource>\n   <pmid>\n    8212560\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1993 Aug;67(8):4972-80\n   </refsource>\n   <pmid>\n    8331736\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1993 Oct;67(10):6159-69\n   </refsource>\n   <pmid>\n    8371356\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1993 Nov;67(11):6387-94\n   </refsource>\n   <pmid>\n    8411340\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1993 Nov;67(11):6487-98\n   </refsource>\n   <pmid>\n    8411352\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Biochemistry. 1996 Jan 9;35(1):132-43\n   </refsource>\n   <pmid>\n    8555166\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1996 Jun 15;220(2):530-4\n   </refsource>\n   <pmid>\n    8661406\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1996 Sep;70(9):5916-21\n   </refsource>\n   <pmid>\n    8709212\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7577-81\n   </refsource>\n   <pmid>\n    8755517\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1996 Aug;70(8):4996-5004\n   </refsource>\n   <pmid>\n    8764006\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Curr Opin Struct Biol. 1998 Apr;8(2):166-76\n   </refsource>\n   <pmid>\n    9631289\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Cell. 1997 Aug 22;90(4):661-70\n   </refsource>\n   <pmid>\n    9288746\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    EMBO J. 1997 Sep 15;16(18):5520-30\n   </refsource>\n   <pmid>\n    9312011\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Science. 1997 Oct 31;278(5339):849-53\n   </refsource>\n   <pmid>\n    9346481\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Science. 1998 Jan 16;279(5349):384-8\n   </refsource>\n   <pmid>\n    9430589\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Feb;72(2):1610-5\n   </refsource>\n   <pmid>\n    9445065\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Curr Opin Cell Biol. 1998 Feb;10(1):23-34\n   </refsource>\n   <pmid>\n    9484592\n   </pmid>\n  </commentscorrections>\n </commentscorrectionslist>\n <meshheadinglist>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Actins\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Base Sequence\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Gene Products, gag\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV-1\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    physiology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Humans\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Molecular Sequence Data\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Protein Binding\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    physiology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Sequence Deletion\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Virus Assembly\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Virus Replication\n   </descriptorname>\n  </meshheading>\n </meshheadinglist>\n <otherid source=\"NLM\">\n  PMC104048\n </otherid>\n</medlinecitation>\n<pubmeddata>\n <history>\n  <pubmedpubdate pubstatus=\"pubmed\">\n   <year>\n    1999\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    12\n   </day>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"medline\">\n   <year>\n    1999\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    12\n   </day>\n   <hour>\n    0\n   </hour>\n   <minute>\n    1\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"entrez\">\n   <year>\n    1999\n   </year>\n   <month>\n    3\n   </month>\n   <day>\n    12\n   </day>\n   <hour>\n    0\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n </history>\n <publicationstatus>\n  ppublish\n </publicationstatus>\n <articleidlist>\n  <articleid idtype=\"pubmed\">\n   10074138\n  </articleid>\n  <articleid idtype=\"pmc\">\n   PMC104048\n  </articleid>\n </articleidlist>\n</pubmeddata>\n</pubmedarticle>\n", 
            "PMID": 10074138, 
            "HasMut": false, 
            "PMCID": "PMC104048"
        }
    }, 
    {
        "pk": 11, 
        "model": "Interaction.article", 
        "fields": {
            "Title": null, 
            "PMCXML": "<?xml version='1.0' encoding='utf-8'?>\n<!DOCTYPE pmc-articleset PUBLIC \"-//PMC//DTD ARTICLE SET 2.0//EN\" \"http://www.pubmedcentral.nih.gov/pmcdoc/dtd/nlm_lib/articleset/nlm-articleset-2.0.dtd\">\n<pmc-articleset>\n <article xmlns:xlink=\"http://www.w3.org/1999/xlink\" article-type=\"research-article\">\n  <!--The publisher of this article does not allow downloading of the full text in XML form.-->\n  <front>\n   <journal-meta>\n    <journal-id journal-id-type=\"nlm-ta\">\n     J Virol\n    </journal-id>\n    <journal-id journal-id-type=\"publisher-id\">\n     jvi\n    </journal-id>\n    <journal-title>\n     Journal of Virology\n    </journal-title>\n    <issn pub-type=\"ppub\">\n     0022-538X\n    </issn>\n    <issn pub-type=\"epub\">\n     1098-5514\n    </issn>\n    <publisher>\n     <publisher-name>\n      American Society for Microbiology\n     </publisher-name>\n    </publisher>\n   </journal-meta>\n   <article-meta>\n    <article-id pub-id-type=\"pmc\">\n     368750\n    </article-id>\n    <article-id pub-id-type=\"pmid\">\n     14694110\n    </article-id>\n    <article-id pub-id-type=\"publisher-id\">\n     1160\n    </article-id>\n    <article-id pub-id-type=\"doi\">\n     10.1128/JVI.78.2.779-789.2004\n    </article-id>\n    <article-categories>\n     <subj-group subj-group-type=\"heading\">\n      <subject>\n       Virus-Cell Interactions\n      </subject>\n     </subj-group>\n    </article-categories>\n    <title-group>\n     <article-title>\n      Human Immunodeficiency Virus Type 1 Tat Regulates Endothelial Cell Actin Cytoskeletal Dynamics through PAK1 Activation and Oxidant Production\n     </article-title>\n    </title-group>\n    <contrib-group>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Wu\n       </surname>\n       <given-names>\n        Ru Feng\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       1\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Gu\n       </surname>\n       <given-names>\n        Ying\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       1\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Xu\n       </surname>\n       <given-names>\n        You Cheng\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       1\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Mitola\n       </surname>\n       <given-names>\n        Stefania\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       2\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Bussolino\n       </surname>\n       <given-names>\n        Federico\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       2\n      </xref>\n     </contrib>\n     <contrib contrib-type=\"author\">\n      <name>\n       <surname>\n        Terada\n       </surname>\n       <given-names>\n        Lance S.\n       </given-names>\n      </name>\n      <xref ref-type=\"aff\" rid=\"aff1\">\n       1\n      </xref>\n      <xref ref-type=\"corresp\" rid=\"cor1\">\n       &#x0002a;\n      </xref>\n     </contrib>\n    </contrib-group>\n    <aff id=\"aff1\">\n     The University of Texas Southwestern Medical Center and the Dallas Veterans Administration Medical Center, Dallas, Texas,\n     <label>\n      1\n     </label>\n     The Institute for Cancer Research and Treatment and University of Turin, Turin, Italy\n     <label>\n      2\n     </label>\n    </aff>\n    <author-notes>\n     <fn id=\"cor1\">\n      <label>\n       &#x0002a;\n      </label>\n      <p>\n       Corresponding author. Mailing address: Dallas VAMC, MC151, 4500 S. Lancaster Rd., Dallas, TX 75216. Phone: (214) 857-0405. Fax: (214) 857-0340. E-mail:\n       <email>\n        lance.terada&#x00040;med.va.gov\n       </email>\n       .\n      </p>\n     </fn>\n    </author-notes>\n    <pub-date pub-type=\"ppub\">\n     <month>\n      1\n     </month>\n     <year>\n      2004\n     </year>\n    </pub-date>\n    <volume>\n     78\n    </volume>\n    <issue>\n     2\n    </issue>\n    <fpage>\n     779\n    </fpage>\n    <lpage>\n     789\n    </lpage>\n    <history>\n     <date date-type=\"received\">\n      <day>\n       16\n      </day>\n      <month>\n       6\n      </month>\n      <year>\n       2003\n      </year>\n     </date>\n     <date date-type=\"accepted\">\n      <day>\n       28\n      </day>\n      <month>\n       9\n      </month>\n      <year>\n       2003\n      </year>\n     </date>\n    </history>\n    <copyright-statement>\n     Copyright &#x000a9; 2004, American Society for Microbiology\n    </copyright-statement>\n    <copyright-year>\n     2004\n    </copyright-year>\n    <abstract>\n     <p>\n      Human immunodeficiency virus type 1 Tat exerts prominent angiogenic effects which may lead to a variety of vasculopathic conditions in AIDS patients. Because endothelial cells undergo prominent cytoskeletal rearrangement during angiogenesis, we investigated the specific effects of Tat on the endothelial cell actin cytoskeleton. Glutathione\n      <italic>\n       S\n      </italic>\n      -transferase (GST)-Tat, at a level of 200 ng/ml (equivalent to 52 ng of Tat/ml), caused stress fiber disassembly, peripheral retraction, and ruffle formation in human umbilical vein endothelial cells (HUVEC) and human lung microvascular endothelial cells. At 600 ng of GST-Tat/ml (157 ng of Tat/ml), actin structures were lost, and severe cytoskeletal collapse occurred. In contrast, GST-Tat harboring mutations within either the cysteine-rich or basic domains exerted minimal effects on the endothelial cytoskeleton. HUVEC expressing a DsRed-Tat fusion protein displayed similar actin rearrangements, followed by actin collapse, whereas neighboring nontransfected cells retained normal actin structures. Because active mutants of p21-activated kinase 1 (PAK1) induce identical changes in actin dynamics, we hypothesized that Tat exerts its cytoskeletal effects through PAK1. GST-Tat activated PAK1 within 5 min, and adenovirus delivery of a kinase-dead PAK1 [PAK1(K298A)] completely prevented cytoskeletal collapse induced by GST-Tat or DsRed-Tat and also blocked downstream activation of c-Jun N-terminal kinase. Further, GST-Tat increased phosphorylation of the NADPH oxidase subunit p47\n      <sup>\n       <italic>\n        phox\n       </italic>\n      </sup>\n      and caused its rapid redistribution to membrane ruffles. PAK1(K298A) blocked p47\n      <sup>\n       <italic>\n        phox\n       </italic>\n      </sup>\n      phosphorylation, and interference with NADPH oxidase function through superoxide scavenging or through expression of a transdominant inhibitor, p67(V204A), prevented GST-Tat-induced alterations in the actin cytoskeleton. We conclude that Tat induces actin cytoskeletal rearrangements through PAK1 and downstream activation of the endothelial NADPH oxidase.\n     </p>\n    </abstract>\n   </article-meta>\n  </front>\n </article>\n</pmc-articleset>\n", 
            "Interactions": [
                665, 
                671, 
                679, 
                690, 
                698, 
                706, 
                2474, 
                4393
            ], 
            "PubMedXML": "<pubmedarticle>\n<medlinecitation owner=\"NLM\" status=\"MEDLINE\">\n <pmid>\n  14694110\n </pmid>\n <datecreated>\n  <year>\n   2003\n  </year>\n  <month>\n   12\n  </month>\n  <day>\n   24\n  </day>\n </datecreated>\n <datecompleted>\n  <year>\n   2004\n  </year>\n  <month>\n   02\n  </month>\n  <day>\n   11\n  </day>\n </datecompleted>\n <daterevised>\n  <year>\n   2009\n  </year>\n  <month>\n   11\n  </month>\n  <day>\n   18\n  </day>\n </daterevised>\n <article pubmodel=\"Print\">\n  <journal>\n   <issn issntype=\"Print\">\n    0022-538X\n   </issn>\n   <journalissue citedmedium=\"Print\">\n    <volume>\n     78\n    </volume>\n    <issue>\n     2\n    </issue>\n    <pubdate>\n     <year>\n      2004\n     </year>\n     <month>\n      Jan\n     </month>\n    </pubdate>\n   </journalissue>\n   <title>\n    Journal of virology\n   </title>\n   <isoabbreviation>\n    J. Virol.\n   </isoabbreviation>\n  </journal>\n  <articletitle>\n   Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.\n  </articletitle>\n  <pagination>\n   <medlinepgn>\n    779-89\n   </medlinepgn>\n  </pagination>\n  <abstract>\n   <abstracttext>\n    Human immunodeficiency virus type 1 Tat exerts prominent angiogenic effects which may lead to a variety of vasculopathic conditions in AIDS patients. Because endothelial cells undergo prominent cytoskeletal rearrangement during angiogenesis, we investigated the specific effects of Tat on the endothelial cell actin cytoskeleton. Glutathione S-transferase (GST)-Tat, at a level of 200 ng/ml (equivalent to 52 ng of Tat/ml), caused stress fiber disassembly, peripheral retraction, and ruffle formation in human umbilical vein endothelial cells (HUVEC) and human lung microvascular endothelial cells. At 600 ng of GST-Tat/ml (157 ng of Tat/ml), actin structures were lost, and severe cytoskeletal collapse occurred. In contrast, GST-Tat harboring mutations within either the cysteine-rich or basic domains exerted minimal effects on the endothelial cytoskeleton. HUVEC expressing a DsRed-Tat fusion protein displayed similar actin rearrangements, followed by actin collapse, whereas neighboring nontransfected cells retained normal actin structures. Because active mutants of p21-activated kinase 1 (PAK1) induce identical changes in actin dynamics, we hypothesized that Tat exerts its cytoskeletal effects through PAK1. GST-Tat activated PAK1 within 5 min, and adenovirus delivery of a kinase-dead PAK1 [PAK1(K298A)] completely prevented cytoskeletal collapse induced by GST-Tat or DsRed-Tat and also blocked downstream activation of c-Jun N-terminal kinase. Further, GST-Tat increased phosphorylation of the NADPH oxidase subunit p47(phox) and caused its rapid redistribution to membrane ruffles. PAK1(K298A) blocked p47(phox) phosphorylation, and interference with NADPH oxidase function through superoxide scavenging or through expression of a transdominant inhibitor, p67(V204A), prevented GST-Tat-induced alterations in the actin cytoskeleton. We conclude that Tat induces actin cytoskeletal rearrangements through PAK1 and downstream activation of the endothelial NADPH oxidase.\n   </abstracttext>\n  </abstract>\n  <affiliation>\n   The University of Texas Southwestern Medical Center and the Dallas Veterans Administration Medical Center, Dallas, Texas 75216, USA.\n  </affiliation>\n  <authorlist completeyn=\"Y\">\n   <author validyn=\"Y\">\n    <lastname>\n     Wu\n    </lastname>\n    <forename>\n     Ru Feng\n    </forename>\n    <initials>\n     RF\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Gu\n    </lastname>\n    <forename>\n     Ying\n    </forename>\n    <initials>\n     Y\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Xu\n    </lastname>\n    <forename>\n     You Cheng\n    </forename>\n    <initials>\n     YC\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Mitola\n    </lastname>\n    <forename>\n     Stefania\n    </forename>\n    <initials>\n     S\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Bussolino\n    </lastname>\n    <forename>\n     Federico\n    </forename>\n    <initials>\n     F\n    </initials>\n   </author>\n   <author validyn=\"Y\">\n    <lastname>\n     Terada\n    </lastname>\n    <forename>\n     Lance S\n    </forename>\n    <initials>\n     LS\n    </initials>\n   </author>\n  </authorlist>\n  <language>\n   eng\n  </language>\n  <grantlist completeyn=\"Y\">\n   <grant>\n    <grantid>\n     R01-HL061897\n    </grantid>\n    <acronym>\n     HL\n    </acronym>\n    <agency>\n     NHLBI NIH HHS\n    </agency>\n    <country>\n     United States\n    </country>\n   </grant>\n   <grant>\n    <grantid>\n     R01-HL067256\n    </grantid>\n    <acronym>\n     HL\n    </acronym>\n    <agency>\n     NHLBI NIH HHS\n    </agency>\n    <country>\n     United States\n    </country>\n   </grant>\n  </grantlist>\n  <publicationtypelist>\n   <publicationtype>\n    Journal Article\n   </publicationtype>\n   <publicationtype>\n    Research Support, U.S. Gov't, Non-P.H.S.\n   </publicationtype>\n   <publicationtype>\n    Research Support, U.S. Gov't, P.H.S.\n   </publicationtype>\n  </publicationtypelist>\n </article>\n <medlinejournalinfo>\n  <country>\n   United States\n  </country>\n  <medlineta>\n   J Virol\n  </medlineta>\n  <nlmuniqueid>\n   0113724\n  </nlmuniqueid>\n  <issnlinking>\n   0022-538X\n  </issnlinking>\n </medlinejournalinfo>\n <chemicallist>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Actins\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Gene Products, tat\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    Recombinant Fusion Proteins\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    0\n   </registrynumber>\n   <nameofsubstance>\n    tat Gene Products, Human Immunodeficiency Virus\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    EC 1.6.3.1\n   </registrynumber>\n   <nameofsubstance>\n    NADPH Oxidase\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    EC 2.5.1.18\n   </registrynumber>\n   <nameofsubstance>\n    Glutathione Transferase\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    EC 2.7.11.1\n   </registrynumber>\n   <nameofsubstance>\n    PAK1 protein, human\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    EC 2.7.11.1\n   </registrynumber>\n   <nameofsubstance>\n    Protein-Serine-Threonine Kinases\n   </nameofsubstance>\n  </chemical>\n  <chemical>\n   <registrynumber>\n    EC 2.7.11.1\n   </registrynumber>\n   <nameofsubstance>\n    p21-Activated Kinases\n   </nameofsubstance>\n  </chemical>\n </chemicallist>\n <citationsubset>\n  IM\n </citationsubset>\n <commentscorrectionslist>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    EMBO J. 2001 Nov 1;20(21):5919-28\n   </refsource>\n   <pmid>\n    11689432\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 2001 Jul 20;286(1):62-71\n   </refsource>\n   <pmid>\n    11448159\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Circ Res. 2002 Apr 5;90(6):697-702\n   </refsource>\n   <pmid>\n    11934838\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 2002 Aug 2;277(31):28051-7\n   </refsource>\n   <pmid>\n    12023963\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 2003 May 9;278(19):17210-7\n   </refsource>\n   <pmid>\n    12618429\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Nature. 1988 Oct 13;335(6191):606-11\n   </refsource>\n   <pmid>\n    2845275\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Am J Pathol. 1983 Apr;111(1):62-77\n   </refsource>\n   <pmid>\n    6301283\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Proc Natl Acad Sci U S A. 1995 May 23;92(11):4838-42\n   </refsource>\n   <pmid>\n    7539135\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Nature. 1995 Jun 8;375(6531):497-500\n   </refsource>\n   <pmid>\n    7539892\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    AIDS. 1996 Jun;10(7):701-10\n   </refsource>\n   <pmid>\n    8805860\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Nat Med. 1996 Dec;2(12):1371-5\n   </refsource>\n   <pmid>\n    8946838\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Am J Pathol. 1996 Dec;149(6):1887-98\n   </refsource>\n   <pmid>\n    8952525\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Mol Cell Biol. 1997 Mar;17(3):1129-43\n   </refsource>\n   <pmid>\n    9032240\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Histochem Cell Biol. 1997 Sep;108(3):221-33\n   </refsource>\n   <pmid>\n    9342616\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Mol Cell Biol. 1998 Apr;18(4):2153-63\n   </refsource>\n   <pmid>\n    9528787\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 1998 Jul;72(7):6131-7\n   </refsource>\n   <pmid>\n    9621077\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 1998 Jul 3;273(27):16663-8\n   </refsource>\n   <pmid>\n    9642219\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 1998 Oct 9;273(41):26722-8\n   </refsource>\n   <pmid>\n    9756915\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 1998 Oct 23;273(43):28191-8\n   </refsource>\n   <pmid>\n    9774440\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Virology. 1998 Dec 5;252(1):126-36\n   </refsource>\n   <pmid>\n    9875323\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Blood. 1999 Jul 15;94(2):663-72\n   </refsource>\n   <pmid>\n    10397733\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 1999 Nov 19;274(47):33644-53\n   </refsource>\n   <pmid>\n    10559253\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Virol. 2000 Jan;74(1):344-53\n   </refsource>\n   <pmid>\n    10590123\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Trends Pharmacol Sci. 2000 Feb;21(2):45-8\n   </refsource>\n   <pmid>\n    10664605\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Circ Res. 2000 Mar 17;86(5):549-57\n   </refsource>\n   <pmid>\n    10720417\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    J Biol Chem. 2000 Apr 21;275(16):12041-50\n   </refsource>\n   <pmid>\n    10766836\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    AIDS. 2000 Mar 31;14(5):475-82\n   </refsource>\n   <pmid>\n    10780709\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Mol Biol Cell. 2000 Oct;11(10):3341-52\n   </refsource>\n   <pmid>\n    11029040\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Biochem J. 2001 Feb 1;353(Pt 3):569-78\n   </refsource>\n   <pmid>\n    11171054\n   </pmid>\n  </commentscorrections>\n  <commentscorrections reftype=\"Cites\">\n   <refsource>\n    Exp Cell Res. 2002 Jan 1;272(1):62-74\n   </refsource>\n   <pmid>\n    11740866\n   </pmid>\n  </commentscorrections>\n </commentscorrectionslist>\n <meshheadinglist>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Actins\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Cells, Cultured\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Cytoskeleton\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Endothelial Cells\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    ultrastructure\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Endothelium, Vascular\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    virology\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Enzyme Activation\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"Y\">\n    Gene Expression Regulation\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Gene Products, tat\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Glutathione Transferase\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    HIV-1\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    metabolism\n   </qualifiername>\n   <qualifiername majortopicyn=\"Y\">\n    pathogenicity\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Humans\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    NADPH Oxidase\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Protein-Serine-Threonine Kinases\n   </descriptorname>\n   <qualifiername majortopicyn=\"Y\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Recombinant Fusion Proteins\n   </descriptorname>\n   <qualifiername majortopicyn=\"N\">\n    genetics\n   </qualifiername>\n   <qualifiername majortopicyn=\"N\">\n    metabolism\n   </qualifiername>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Transduction, Genetic\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    Umbilical Veins\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    p21-Activated Kinases\n   </descriptorname>\n  </meshheading>\n  <meshheading>\n   <descriptorname majortopicyn=\"N\">\n    tat Gene Products, Human Immunodeficiency Virus\n   </descriptorname>\n  </meshheading>\n </meshheadinglist>\n <otherid source=\"NLM\">\n  PMC368750\n </otherid>\n</medlinecitation>\n<pubmeddata>\n <history>\n  <pubmedpubdate pubstatus=\"pubmed\">\n   <year>\n    2003\n   </year>\n   <month>\n    12\n   </month>\n   <day>\n    25\n   </day>\n   <hour>\n    5\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"medline\">\n   <year>\n    2004\n   </year>\n   <month>\n    2\n   </month>\n   <day>\n    12\n   </day>\n   <hour>\n    5\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n  <pubmedpubdate pubstatus=\"entrez\">\n   <year>\n    2003\n   </year>\n   <month>\n    12\n   </month>\n   <day>\n    25\n   </day>\n   <hour>\n    5\n   </hour>\n   <minute>\n    0\n   </minute>\n  </pubmedpubdate>\n </history>\n <publicationstatus>\n  ppublish\n </publicationstatus>\n <articleidlist>\n  <articleid idtype=\"pubmed\">\n   14694110\n  </articleid>\n  <articleid idtype=\"pmc\">\n   PMC368750\n  </articleid>\n </articleidlist>\n</pubmeddata>\n</pubmedarticle>\n", 
            "PMID": 14694110, 
            "HasMut": false, 
            "PMCID": "PMC368750"
        }
    }, 
    {
        "pk": 73, 
        "model": "Interaction.sentence", 
        "fields": {
            "RandOrder": 0.59365921895680795, 
            "Text": "Purified recombinant NCp7, but not CAp24, was able to bind F-actin in cosedimentation experiments. Furthermore, wild-type NCp7 and a zinc finger mutant NCp7(F16A), like a cellular actin-binding protein (the villin headpiece), bound F-actin in a dose-dependent fashion in vitro.", 
            "Priority": null, 
            "SentNum": 7, 
            "Article": 18, 
            "PMID": null, 
            "ParNum": 1, 
            "Mutation": [
                3
            ]
        }
    }, 
    {
        "pk": 72, 
        "model": "Interaction.sentence", 
        "fields": {
            "RandOrder": 0.100289922472641, 
            "Text": "Further, GST-Tat increased phosphorylation of the NADPH oxidase subunit p47phoxand caused its rapid redistribution to membrane ruffles. PAK1(K298A) blocked p47phoxphosphorylation, and interference with NADPH oxidase function through superoxide scavenging or through expression of a transdominant inhibitor, p67(V204A), prevented GST-Tat-induced alterations in the actin cytoskeleton.", 
            "Priority": null, 
            "SentNum": 10, 
            "Article": 11, 
            "PMID": null, 
            "ParNum": 1, 
            "Mutation": [
                1
            ]
        }
    }, 
    {
        "pk": 71, 
        "model": "Interaction.sentence", 
        "fields": {
            "RandOrder": 0.42722083205680861, 
            "Text": "Because active mutants of p21-activated kinase 1 (PAK1) induce identical changes in actin dynamics, we hypothesized that Tat exerts its cytoskeletal effects through PAK1. GST-Tat activated PAK1 within 5 min, and adenovirus delivery of a kinase-dead PAK1 [PAK1(K298A)] completely prevented cytoskeletal collapse induced by GST-Tat or DsRed-Tat and also blocked downstream activation of c-Jun N-terminal kinase.", 
            "Priority": null, 
            "SentNum": 8, 
            "Article": 11, 
            "PMID": null, 
            "ParNum": 1, 
            "Mutation": [
                1
            ]
        }
    }
]
